Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD

Samer Gawrieh, Miranda C. Marion, Richard Komorowski, James Wallace, Michael Charlton, Ahmed Kissebah, Carl D. Langefeld, Michael Olivier

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Background The peroxisome proliferator activated receptorgamma (PPARG) is a nuclear receptor that regulates adipocyte differentiation, insulin sensitivity and lipid metabolism, thus, it represents a good candidate gene for non-alcoholic fatty liver disease (NAFLD). Purpose and Method We investigated the association of two PPARG variants (Pro12Ala and C1431T) with NAFLD and its histological features. DNA was extracted from 274 archived, formalin-fixed liver biopsy specimens from 212 patients with NAFLD and 62 controls with normal liver histology. Results Individual SNPs did not show significant association with NAFLD or its histological features. A haplotype comprised of both minor alleles (GT) was less enriched whereas a haplotype comprised of the two major alleles (CC) was more enriched in subjects with NAFLD compared to controls [9.3% vs. 28.1% for GT (P = 0.001, OR 0.26 (range 0.14-0.48) and 80.4% vs. 64.8% for CC (P = 0.037, OR 2.23 (range 1.30-3.81)]. Both haplotypes were significantly associated with steatosis and fibrosis. The GT haplotype was also associated with lobular inflammation. Conclusions Genetic variation in PPARG is associated with NAFLD, and the GT haplotype is associated with inflammatory and fibrotic changes that denote histologically advanced NAFLD.

Original languageEnglish (US)
Pages (from-to)952-957
Number of pages6
JournalDigestive Diseases and Sciences
Volume57
Issue number4
DOIs
StatePublished - Apr 2012
Externally publishedYes

Fingerprint

PPAR gamma
Haplotypes
Peroxisome Proliferators
Genes
Alleles
Liver
Cytoplasmic and Nuclear Receptors
Non-alcoholic Fatty Liver Disease
Lipid Metabolism
Adipocytes
Formaldehyde
Single Nucleotide Polymorphism
Insulin Resistance
Histology
Fibrosis
Inflammation
Biopsy
DNA

Keywords

  • Gene
  • NAFLD
  • NASH
  • Polymorphism
  • PPAR gamma
  • SNP

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology

Cite this

Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD. / Gawrieh, Samer; Marion, Miranda C.; Komorowski, Richard; Wallace, James; Charlton, Michael; Kissebah, Ahmed; Langefeld, Carl D.; Olivier, Michael.

In: Digestive Diseases and Sciences, Vol. 57, No. 4, 04.2012, p. 952-957.

Research output: Contribution to journalArticle

Gawrieh, Samer ; Marion, Miranda C. ; Komorowski, Richard ; Wallace, James ; Charlton, Michael ; Kissebah, Ahmed ; Langefeld, Carl D. ; Olivier, Michael. / Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD. In: Digestive Diseases and Sciences. 2012 ; Vol. 57, No. 4. pp. 952-957.
@article{a9a06291814e4d09a4f5515cce790f12,
title = "Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD",
abstract = "Background The peroxisome proliferator activated receptorgamma (PPARG) is a nuclear receptor that regulates adipocyte differentiation, insulin sensitivity and lipid metabolism, thus, it represents a good candidate gene for non-alcoholic fatty liver disease (NAFLD). Purpose and Method We investigated the association of two PPARG variants (Pro12Ala and C1431T) with NAFLD and its histological features. DNA was extracted from 274 archived, formalin-fixed liver biopsy specimens from 212 patients with NAFLD and 62 controls with normal liver histology. Results Individual SNPs did not show significant association with NAFLD or its histological features. A haplotype comprised of both minor alleles (GT) was less enriched whereas a haplotype comprised of the two major alleles (CC) was more enriched in subjects with NAFLD compared to controls [9.3{\%} vs. 28.1{\%} for GT (P = 0.001, OR 0.26 (range 0.14-0.48) and 80.4{\%} vs. 64.8{\%} for CC (P = 0.037, OR 2.23 (range 1.30-3.81)]. Both haplotypes were significantly associated with steatosis and fibrosis. The GT haplotype was also associated with lobular inflammation. Conclusions Genetic variation in PPARG is associated with NAFLD, and the GT haplotype is associated with inflammatory and fibrotic changes that denote histologically advanced NAFLD.",
keywords = "Gene, NAFLD, NASH, Polymorphism, PPAR gamma, SNP",
author = "Samer Gawrieh and Marion, {Miranda C.} and Richard Komorowski and James Wallace and Michael Charlton and Ahmed Kissebah and Langefeld, {Carl D.} and Michael Olivier",
year = "2012",
month = "4",
doi = "10.1007/s10620-011-1994-2",
language = "English (US)",
volume = "57",
pages = "952--957",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD

AU - Gawrieh, Samer

AU - Marion, Miranda C.

AU - Komorowski, Richard

AU - Wallace, James

AU - Charlton, Michael

AU - Kissebah, Ahmed

AU - Langefeld, Carl D.

AU - Olivier, Michael

PY - 2012/4

Y1 - 2012/4

N2 - Background The peroxisome proliferator activated receptorgamma (PPARG) is a nuclear receptor that regulates adipocyte differentiation, insulin sensitivity and lipid metabolism, thus, it represents a good candidate gene for non-alcoholic fatty liver disease (NAFLD). Purpose and Method We investigated the association of two PPARG variants (Pro12Ala and C1431T) with NAFLD and its histological features. DNA was extracted from 274 archived, formalin-fixed liver biopsy specimens from 212 patients with NAFLD and 62 controls with normal liver histology. Results Individual SNPs did not show significant association with NAFLD or its histological features. A haplotype comprised of both minor alleles (GT) was less enriched whereas a haplotype comprised of the two major alleles (CC) was more enriched in subjects with NAFLD compared to controls [9.3% vs. 28.1% for GT (P = 0.001, OR 0.26 (range 0.14-0.48) and 80.4% vs. 64.8% for CC (P = 0.037, OR 2.23 (range 1.30-3.81)]. Both haplotypes were significantly associated with steatosis and fibrosis. The GT haplotype was also associated with lobular inflammation. Conclusions Genetic variation in PPARG is associated with NAFLD, and the GT haplotype is associated with inflammatory and fibrotic changes that denote histologically advanced NAFLD.

AB - Background The peroxisome proliferator activated receptorgamma (PPARG) is a nuclear receptor that regulates adipocyte differentiation, insulin sensitivity and lipid metabolism, thus, it represents a good candidate gene for non-alcoholic fatty liver disease (NAFLD). Purpose and Method We investigated the association of two PPARG variants (Pro12Ala and C1431T) with NAFLD and its histological features. DNA was extracted from 274 archived, formalin-fixed liver biopsy specimens from 212 patients with NAFLD and 62 controls with normal liver histology. Results Individual SNPs did not show significant association with NAFLD or its histological features. A haplotype comprised of both minor alleles (GT) was less enriched whereas a haplotype comprised of the two major alleles (CC) was more enriched in subjects with NAFLD compared to controls [9.3% vs. 28.1% for GT (P = 0.001, OR 0.26 (range 0.14-0.48) and 80.4% vs. 64.8% for CC (P = 0.037, OR 2.23 (range 1.30-3.81)]. Both haplotypes were significantly associated with steatosis and fibrosis. The GT haplotype was also associated with lobular inflammation. Conclusions Genetic variation in PPARG is associated with NAFLD, and the GT haplotype is associated with inflammatory and fibrotic changes that denote histologically advanced NAFLD.

KW - Gene

KW - NAFLD

KW - NASH

KW - Polymorphism

KW - PPAR gamma

KW - SNP

UR - http://www.scopus.com/inward/record.url?scp=84864073994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864073994&partnerID=8YFLogxK

U2 - 10.1007/s10620-011-1994-2

DO - 10.1007/s10620-011-1994-2

M3 - Article

VL - 57

SP - 952

EP - 957

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 4

ER -